A prospective cohort study to determine immunogenicity of COVID-19 mRNA vaccines in pregnant and lactating women , including against emerging SARS-CoV-2 variants of concern
Latest Information Update: 20 May 2021
At a glance
- Drugs Elasomeran (Primary) ; Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Pharmacodynamics
- 20 May 2021 New trial record
- 13 May 2021 Results published in the JAMA: the Journal of the American Medical Association